Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

HIV/AIDS gene therapy work continues with NIH funds

South Africa Time — Friday, February 22, 2013

HIV/AIDS gene therapy work continues with NIH funds:

Trobridge PULLMAN, Wash. – Grant D. Trobridge of Washington State University has received a $1.6 million grant from the National Institutes of Health to continue investigating the use of gene therapy for HIV and AIDS, an area where he has had success.

LEGACY - for researchers

Top stories of the last 30 days

New approach to HIV treatment offers hope to reduce daily drug needs

South Africa Time — Thursday, February 05, 2026

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the ... View article...

Digital health system boosts family planning, HIV services in rural areas

South Africa Time — Thursday, February 05, 2026

... HIV /AIDS education at community level. "Family planning enables individuals and couples to make informed choices, and the access expansion to ... View article...

Wistar Scientists Demonstrate First-Ever Single-Shot HIV Vaccine Neutralization Success

South Africa Time — Thursday, February 05, 2026

Scientists at The Wistar Institute have developed an HIV vaccine candidate that induces neutralizing antibodies against HIV after a single ... View article...

First of its kind daily HIV treatment shows promising results

South Africa Time — Monday, February 09, 2026

All of the currently recommended HIV treatment regimens include an integrase strand-transfer inhibitor (INSTI) – a drug that blocks the integration of ... View article...

HIV drug's Medicare costs under negotiation

South Africa Time — Monday, February 02, 2026

The government will negotiate the price of Biktarvy with drugmaker Gilead Sciences. bottle of HIV suppressing drug Biktarvy. The Centers for Medicare ... View article...

African scientists drive new hope for an HIV cure

South Africa Time — Wednesday, February 04, 2026

... ( HIV ) vaccine trials signal a potential turning point in the decades-long fight against HIV /AIDS. Designed and implemented by African scientists ... View article...

Black HIV / AIDS awareness

South Africa Time — Thursday, February 05, 2026

“Black men are twelve times more likely to be HIV -positive than white men,” said advocate Creola Hampton, “and there are fourteen times more Black ... View article...

'DNA origami' could be key for making an effective HIV vaccine, early study hints

South Africa Time — Thursday, February 12, 2026

A vaccine designed using "DNA origami" activated more of the key immune cells needed to fight HIV than did traditional vaccines built upon protein ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Zimbabwe begins roll-out of new HIV prevention drug

South Africa Time — Thursday, February 19, 2026

Zimbabwean health authorities began administering the long-acting HIV prevention drug Lenacapavir, becoming one of the first countries in the ... View article...

Federal appeals court sides with Pentagon against science, reinstating U.S. military's HIV ...

South Africa Time — Thursday, February 19, 2026

In a ruling that reasserts broad judicial deference to the U.S. military and delivers a major setback to HIV and LGBTQ+ advocates, ... View article...

Single Immunization Produces Broad HIV Neutralization in Mouse Model, Pointing to ...

South Africa Time — Wednesday, February 18, 2026

... HIV strains, thereby offering a potential path toward simpler HIV vaccine regimens. Developing an effective HIV vaccine has proven exceptionally ... View article...

4th Circuit panel upholds military ban on enlisting HIV-positive individuals

South Africa Time — Thursday, February 19, 2026

She analyzed anew the issues presented and came to the same conclusion: that refusing to enlist asymptomatic HIV -positive individuals was not a ... View article...

Exposing a hidden anchor for HIV replication

South Africa Time — Wednesday, February 18, 2026

... HIV protein, earlier in the virus' life cycle when it matures into an infectious force. The team's goal is to identify new targets for drugs that ... View article...

UAB leads study to mitigate the medication adherence barriers in those living with HIV

South Africa Time — Thursday, February 19, 2026

In infectious diseases like HIV , in addition to impacting individual health, reduced adherence to medications also results in ongoing transmission of ... View article...

Cancer and HIV Vaccines Enter the Therapeutic Era

South Africa Time — Thursday, February 19, 2026

Therapeutic vaccines are advancing in oncology and HIV , with the aim of retraining immune responses to target tumors and persistent viral ... View article...

Exposing a hidden anchor for HIV replication

South Africa Time — Thursday, February 19, 2026

The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it. View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews